AccessDx Laboratory

AccessDx Laboratory is a clinical diagnostics company founded in 2016, specializing in molecular diagnostics, pharmacogenomics, and genomics solutions. It is CLIA-certified, CAP-accredited, and NYSDOH-approved, providing precision medicine insights to enhance patient outcomes. The company boasts a multidisciplinary team of experts, including laboratorians, scientists, and clinical leaders, serving over 2,000 clients nationwide, including healthcare providers, employers, municipalities, and consultancies. AccessDx offers advanced molecular diagnostic testing through its digital platform, MedTek21, which facilitates seamless ordering and decision support. Key services include pharmacogenomics profiles for optimizing prescriptions, infectious disease testing for microbial detection, and hereditary cancer testing to identify genetic variants. The company emphasizes operational excellence, innovation, and health equity, ensuring fast turnaround times for test results, such as COVID-19 results in under 48 hours. With 250 years of collective experience in precision medicine, AccessDx is dedicated to democratizing access to quality diagnostics.